title: How to manage Waldenstrom's macroglobulinemia.
abstract: Waldenstrom's macroglobulinemia (WM) is very distinct from other indolent lymphoma subtypes: by definition it is accompanied by a monoclonal IgM gammopathy; it presents always with bone marrow infiltration and often with clinical symptoms such as neuropathy or hyperviscosity. These disease characteristics and the frequently advanced age of the WM patient pose a major challenge to the treating clinician even today. Recently, there has been not only substantial progress in our understanding of the biology of WM, but we have also significantly improved our tools to prognostify and to treat patients with this disease. This review summarizes our current knowledge about WM and aims at offering a guideline for the clinical management of patients with this lymphoma subtype, covering questions on how to manage diagnosis, prognostification and treatment based on the most recent data.
authors: Comprehensive Cancer Center Ulm, Institute of Experimental Cancer Research, University Hospital Ulm, Ulm, Germany. christian.buske@uni-ulm.de
authors: C
authors: C
authors: Buske
authors: V
authors: V
authors: Leblond
mesh_terms: D000368:Aged; D006801:Humans; D011379:Prognosis; D008258:Waldenstrom Macroglobulinemia / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*
references: Br J Haematol. 2011 May;153(3):309-17
references: 21385173
references: J Clin Oncol. 2010 Mar 10;28(8):1408-14
references: 20142598
references: Blood. 2013 Feb 21;121(8):1296-303
references: 23287861
references: Mayo Clin Proc. 2010 Sep;85(9):824-33
references: 20702770
references: Eur J Haematol. 1995 Feb;54(2):120-3
references: 7698295
references: Clin Lymphoma Myeloma Leuk. 2011 Feb;11(1):106-8
references: 21454205
references: Am J Hematol. 2010 Sep;85(9):670-4
references: 20652865
references: J Peripher Nerv Syst. 2011 Sep;16(3):180-5
references: 22003932
references: Br J Haematol. 2000 Mar;108(4):737-42
references: 10792277
references: Semin Oncol. 2003 Apr;30(2):110-5
references: 12720118
references: J Clin Oncol. 2007 Apr 20;25(12):1570-5
references: 17353550
references: Blood. 2007 Jun 1;109(11):4964-72
references: 17284528
references: Clin Lymphoma Myeloma. 2005 Sep;6(2):136-9
references: 16231852
references: Ann Oncol. 2006 Mar;17(3):488-94
references: 16357024
references: Blood. 2009 Apr 30;113(18):4391-402
references: 19074725
references: J Clin Oncol. 2001 Aug 15;19(16):3596-601
references: 11504741
references: J Clin Oncol. 2008 Jan 10;26(2):204-10
references: 18182663
references: Blood. 2008 Dec 1;112(12):4452-7
references: 18713945
references: Blood. 2001 Nov 1;98(9):2640-4
references: 11675332
references: Blood. 2007 Dec 15;110(13):4417-26
references: 17761832
references: Semin Oncol. 2003 Apr;30(2):265-9
references: 12720150
references: Br J Haematol. 2007 Jan;136(1):80-6
references: 17222197
references: Clin Cancer Res. 2009 Jan 1;15(1):355-60
references: 19118065
references: Clin Lymphoma Myeloma Leuk. 2011 Feb;11(1):152-6
references: 21454220
references: J Clin Oncol. 2009 Jan 10;27(2):250-5
references: 19064987
references: Clin Cancer Res. 2007 Jun 1;13(11):3320-5
references: 17545538
references: J Clin Oncol. 2010 May 1;28(13):2227-32
references: 20368570
references: Cancer. 2012 Jan 15;118(2):434-43
references: 21732338
references: J Hematol Oncol. 2010 Oct 07;3:38
references: 20929526
references: Semin Oncol. 2003 Apr;30(2):153-5
references: 12720126
references: Semin Oncol. 2003 Apr;30(2):187-95
references: 12720134
references: Biol Blood Marrow Transplant. 2006 Aug;12(8):845-54
references: 16864055
references: J Clin Oncol. 2009 Aug 10;27(23):3830-5
references: 19506160
references: Clin Lymphoma Myeloma. 2009 Mar;9(1):23-6
references: 19362964
references: Clin Lymphoma Myeloma. 2009 Mar;9(1):62-6
references: 19362976
references: J Clin Oncol. 2009 Jan 1;27(1):120-6
references: 19047284
references: Clin Lymphoma Myeloma. 2009 Mar;9(1):77-9
references: 19362980
references: Clin Lymphoma Myeloma. 2009 Mar;9(1):100-3
references: 19362987
references: J Clin Oncol. 2010 Mar 10;28(8):1422-8
references: 20142586
references: N Engl J Med. 2012 Dec 6;367(23):2255-6; author reply 2256-7
references: 23215570
references: J Clin Pathol. 2011 Jun;64(6):520-3
references: 21471142
references: Blood. 2006 Oct 15;108(8):2755-63
references: 16804116
references: Semin Oncol. 2003 Apr;30(2):116-20
references: 12720119
references: J Clin Oncol. 2010 Nov 20;28(33):4926-34
references: 20956626
references: Leukemia. 2009 Jan;23(1):153-61
references: 18818699
references: Haematologica. 2013 Apr;98(4):649-54
references: 23065509
references: Semin Oncol. 2003 Apr;30(2):239-42
references: 12720144
references: J Clin Oncol. 2013 Jan 20;31(3):301-7
references: 23233721
references: Br J Haematol. 2011 Aug;154(3):357-62
references: 21615385
references: Blood. 2009 Jan 22;113(4):793-6
references: 18931340
references: Am J Med. 1993 Jul;95(1):49-52
references: 8328496
references: Nature. 2011 Feb 3;470(7332):115-9
references: 21179087
references: J Clin Oncol. 2007 Aug 1;25(22):3344-9
references: 17577016
references: N Engl J Med. 2012 Aug 30;367(9):826-33
references: 22931316
references: Leukemia. 2005 Oct;19(10):1831-4
references: 16121217
references: Semin Oncol. 2003 Apr;30(2):243-7
references: 12720145
references: Cancer. 1998 Mar 15;82(6):1078-81
references: 9506352
references: Am J Hematol. 2010 Nov;85(11):853-5
references: 20842638
references: Clin Cancer Res. 2010 Feb 1;16(3):1033-41
references: 20103671
references: Blood. 2009 Apr 16;113(16):3673-8
references: 19015393
references: Blood. 2011 Jul 14;118(2):276-81
references: 21566092
references: Clin Lymphoma Myeloma. 2005 Sep;6(2):131-5
references: 16231851
references: Haematologica. 2010 Jun;95(6):950-5
references: 20081058
references: Leukemia. 2013 Jan;27(1):183-9
references: 22944768
references: Clin Lymphoma Myeloma. 2009 Mar;9(1):71-3
references: 19362978
references: Leuk Res. 2008 Jan;32(1):55-9
references: 17416416
references: Clin Cancer Res. 2012 Sep 15;18(18):5043-50
references: 22879385
references: Haematologica. 2005 Dec;90(12):1655-8
references: 16330439
references: J Clin Oncol. 2010 May 1;28(13):2233-8
references: 20368573
references: Hematology Am Soc Hematol Educ Program. 2012;2012:586-94
references: 23233639
references: Blood. 2009 Apr 30;113(18):4163-70
references: 19196866
references: Curr Treat Options Neurol. 2010 Mar;12(2):71-83
references: 20842571
references: Hematology Am Soc Hematol Educ Program. 2004;:257-82
references: 15561687
references: Cancer. 2004 Dec 1;101(11):2593-8
references: 15493038
references: Bone Marrow Transplant. 2012 Sep;47(9):1147-53
references: 21874060
references: Br J Haematol. 2013 Jan;160(2):171-6
references: 23150997